Saturday, February 18, 2017 7:04:08 PM
Over the past couple of years the FDA has withheld approval of many products as a hammer to force companies to bring their plants up to snuff.
They will only withhold products that are to be made in that deficient plant.
In essence the FDA's position is you can't handle what you have so why should we give you more.
You can read up on the major drug the FDA is holding back from Sanofi/Regeneron because of Sanofi's manufacturing plant.
http://www.fiercepharma.com/manufacturing/sanofi-s-and-regeneron-s-expected-blockbuster-runs-into-fda-manufacturing-concerns
FEATURED POET Announces Design Win and Collaboration with Foxconn Interconnect Technology for High-speed AI Systems • May 14, 2024 10:09 AM
FEATURED Element79 Gold Corp Reports Exceptionally High-Grade Results from Lucero • May 14, 2024 7:00 AM
VAYK Added New Manager for Expansion into $64 Billion Domestic Short-term Rental Market • VAYK • May 14, 2024 9:00 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM